Company Overview of The University of Massachusetts Medical School
55 Lake Avenue North
Worcester, MA 01655
Key Executives for The University of Massachusetts Medical School
Director for Diabetes Center of Excellence and Division Chief of Diabetes
Director for the Cancer Center of Excellence
Senior Director of Human Stem Cell Bank & Registry
Compensation as of Fiscal Year 2014.
The University of Massachusetts Medical School Key Developments
Voyager Therapeutics and The University of Massachusetts Medical School Announce Strategic Collaboration for Viral Vector Manufacturing
Dec 11 14
Voyager Therapeutics announced entered into a strategic collaboration with MassBiologics of the University of Massachusetts Medical School (UMMS). Through the collaboration, MassBiologics and Voyager Therapeutics will establish scalable processes for manufacturing recombinant adeno-associated viral (rAAV) vector products using current good manufacturing practices (cGMP). The collaboration will combine Voyager’s rAAV production technology platform with the manufacturing expertise and infrastructure of MassBiologics. Scientists from Voyager and MassBiologics will work together to establish Voyager’s proprietary third generation baculovirus/Sf9 process for the production of rAAV vectors.
The University of Massachusetts Medical School Wins $2.56 Million Federal Contract
Sep 30 14
The University of Massachusetts Medical School won a $2,556,933 federal contract from the U.S. Department of Health and Human Services' National Institutes of Health, Bethesda, Maryland, for large scale T cell epitope discovery.
UMass Medical School Receives Multi-Million Dollar Contract to Manage Health Care at Federal Correctional Institution in New York
May 15 14
The Federal Bureau of Prisons has awarded the University of Massachusetts (UMass) Medical School a multimillion dollar contract to manage comprehensive medical services for nearly 1,000 inmates at the Federal Correctional Institution (FCI) located in Ray Brook, New York. The five-year agreement is valued at a total of $8 million, and becomes UMass Medical School's fourth federal correctional health contract. The Health and Criminal Justice Program, part of UMass Medical School's Commonwealth Medicine division, will manage the contract. The medical school's work at FCI Ray Brook will in the month June. The contract calls for UMass Medical School to coordinate inpatient and outpatient care provided by specialist physicians at the correctional facility and in community settings. The medical school will manage scheduling and handle all claims associated with the care.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries